Erick Lucera - 15 Feb 2022 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.

Role
Chief Financial Officer
Signature
/s/ Danielle V. Holland, attorney-in-fact
Issuer symbol
N/A
Transactions as of
15 Feb 2022
Net transactions value
$0
Form type
4
Filing time
17 Feb 2022, 16:00:17 UTC
Previous filing
28 Feb 2022
Next filing
07 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVEO Stock Option (right to buy) Award $0 +218,800 $0.000000 218,800 15 Feb 2022 Common Stock 218,800 $3.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in equal monthly installments from February 15, 2022 through February 15, 2026, subject to the Reporting Person's continued service to the Company.